Resveratrol downregulates the constitutional activation of nuclear factor-κB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis-Reference-Cited by-同舟云学术

Resveratrol downregulates the constitutional activation of nuclear factor-κB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis

Published:2006-02 Issue:1 Volume:165 Page:9-19
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Sun Chunyan,Hu Yu,Liu Xinyue,Wu Tao,Wang Yadan,He Wenjuan,Wei Wenning

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference59 articles.

1. Multiple myeloma;Bataille;N Engl J Med,1997

2. Management of multiple myeloma today;Anderson;Semin Hematol,1999

3. A new class of phytoalexins from grape-wines;Langcake;Experientia,1997

4. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes;Jang;Science,1997

5. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator;Nakagawa;J Cancer Res Clin Oncol,2001

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer;Medical Oncology;2023-10-19

2. ROS/Redox Regulation with Dietary Phytochemicals and Role in Anticancer Activity;Redox Regulation and Therapeutic Approaches in Cancer;2023

3. Nanotherapeutics of Phytoantioxidants for Inflammatory Disorders;Phytoantioxidants and Nanotherapeutics;2022-09-02

4. Effects of grape phenolics, myricetin and piceatannol, on bovine granulosa and theca cell proliferation and steroid production in vitro;Food and Chemical Toxicology;2022-09

5. Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions;Frontiers in Pharmacology;2022-01-27